Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Nodule | 54 | 2024 | 767 | 11.480 |
Why?
|
Thyroid Neoplasms | 68 | 2024 | 2360 | 7.820 |
Why?
|
Thyroid Gland | 26 | 2022 | 1171 | 3.830 |
Why?
|
Biopsy, Fine-Needle | 37 | 2024 | 1132 | 3.240 |
Why?
|
Clinical Clerkship | 16 | 2022 | 569 | 3.050 |
Why?
|
Carcinoma, Papillary | 16 | 2023 | 793 | 2.380 |
Why?
|
Hypothyroidism | 18 | 2024 | 667 | 2.260 |
Why?
|
Adenocarcinoma, Follicular | 16 | 2020 | 326 | 2.240 |
Why?
|
Thyroid Diseases | 9 | 2022 | 385 | 2.140 |
Why?
|
Pregnancy Complications | 13 | 2024 | 2974 | 1.490 |
Why?
|
Thyrotropin | 17 | 2024 | 834 | 1.400 |
Why?
|
Watchful Waiting | 2 | 2024 | 498 | 1.290 |
Why?
|
Thyroidectomy | 19 | 2022 | 914 | 1.240 |
Why?
|
Thyroxine | 9 | 2024 | 665 | 1.220 |
Why?
|
Carcinoma | 8 | 2023 | 2340 | 1.160 |
Why?
|
Ultrasonography | 24 | 2024 | 6002 | 1.130 |
Why?
|
Education, Medical, Undergraduate | 8 | 2023 | 1085 | 1.040 |
Why?
|
Radiosurgery | 30 | 2000 | 1346 | 1.030 |
Why?
|
Thyroid Function Tests | 8 | 2024 | 289 | 0.990 |
Why?
|
Educational Measurement | 7 | 2020 | 1260 | 0.970 |
Why?
|
Curriculum | 12 | 2023 | 3782 | 0.970 |
Why?
|
Internal Medicine | 5 | 2015 | 1064 | 0.870 |
Why?
|
Cytodiagnosis | 8 | 2019 | 453 | 0.840 |
Why?
|
Hashimoto Disease | 3 | 2019 | 108 | 0.800 |
Why?
|
Neurosurgery | 22 | 2000 | 690 | 0.800 |
Why?
|
Students, Medical | 9 | 2023 | 1964 | 0.790 |
Why?
|
Stereotaxic Techniques | 21 | 1998 | 559 | 0.780 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2019 | 260 | 0.670 |
Why?
|
Education, Medical | 6 | 2015 | 1742 | 0.650 |
Why?
|
Iodine Radioisotopes | 7 | 2018 | 1034 | 0.640 |
Why?
|
Iodide Peroxidase | 7 | 2024 | 295 | 0.630 |
Why?
|
Brain Neoplasms | 56 | 2001 | 9213 | 0.630 |
Why?
|
Humans | 267 | 2025 | 768970 | 0.550 |
Why?
|
Graves Disease | 4 | 2022 | 239 | 0.530 |
Why?
|
Thyrotoxicosis | 4 | 2022 | 85 | 0.510 |
Why?
|
Education, Medical, Graduate | 8 | 2025 | 2422 | 0.500 |
Why?
|
Autoantibodies | 8 | 2024 | 2120 | 0.480 |
Why?
|
Female | 161 | 2025 | 397515 | 0.470 |
Why?
|
Problem-Based Learning | 3 | 2020 | 360 | 0.460 |
Why?
|
Intracranial Arteriovenous Malformations | 7 | 2000 | 366 | 0.450 |
Why?
|
School Admission Criteria | 1 | 2015 | 107 | 0.440 |
Why?
|
Goiter, Nodular | 1 | 2013 | 28 | 0.440 |
Why?
|
Retrospective Studies | 48 | 2024 | 81903 | 0.430 |
Why?
|
Thyroiditis, Subacute | 1 | 2013 | 11 | 0.430 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2023 | 2059 | 0.430 |
Why?
|
Thyrotropin Alfa | 1 | 2012 | 1 | 0.410 |
Why?
|
Male | 141 | 2025 | 365203 | 0.400 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2013 | 115 | 0.400 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2017 | 1769 | 0.400 |
Why?
|
Adult | 118 | 2024 | 223851 | 0.400 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2024 | 529 | 0.390 |
Why?
|
Middle Aged | 110 | 2024 | 223737 | 0.390 |
Why?
|
Clinical Competence | 9 | 2025 | 4860 | 0.390 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2013 | 234 | 0.390 |
Why?
|
Manikins | 2 | 2010 | 254 | 0.380 |
Why?
|
Prospective Studies | 24 | 2024 | 54962 | 0.370 |
Why?
|
Interprofessional Relations | 2 | 2023 | 997 | 0.340 |
Why?
|
Models, Organizational | 1 | 2013 | 549 | 0.340 |
Why?
|
Pregnancy | 23 | 2024 | 30265 | 0.340 |
Why?
|
Practice Guidelines as Topic | 10 | 2020 | 7460 | 0.330 |
Why?
|
Teaching | 4 | 2020 | 1171 | 0.330 |
Why?
|
Aged | 81 | 2024 | 171786 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 19 | 2024 | 9442 | 0.320 |
Why?
|
Cysts | 5 | 2003 | 685 | 0.300 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9549 | 0.300 |
Why?
|
Lymphatic Metastasis | 4 | 2022 | 2916 | 0.290 |
Why?
|
Observer Variation | 2 | 2013 | 2623 | 0.280 |
Why?
|
Carcinoma, Papillary, Follicular | 2 | 2018 | 59 | 0.280 |
Why?
|
Particle Accelerators | 9 | 1994 | 173 | 0.280 |
Why?
|
Hyperthyroidism | 3 | 2022 | 292 | 0.270 |
Why?
|
Aged, 80 and over | 33 | 2024 | 59739 | 0.260 |
Why?
|
Abortion, Spontaneous | 1 | 2011 | 535 | 0.260 |
Why?
|
Models, Educational | 3 | 2012 | 375 | 0.260 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2013 | 1093 | 0.250 |
Why?
|
Autoimmune Diseases | 3 | 2024 | 2258 | 0.250 |
Why?
|
Prognosis | 19 | 2023 | 30046 | 0.250 |
Why?
|
Motivation | 1 | 2015 | 2025 | 0.240 |
Why?
|
Internship and Residency | 6 | 2025 | 5956 | 0.240 |
Why?
|
Medical History Taking | 1 | 2008 | 779 | 0.240 |
Why?
|
Educational Technology | 1 | 2005 | 59 | 0.230 |
Why?
|
Glioblastoma | 15 | 1999 | 3525 | 0.230 |
Why?
|
Sensitivity and Specificity | 11 | 2021 | 14752 | 0.230 |
Why?
|
Iodine | 2 | 2020 | 286 | 0.230 |
Why?
|
Schools, Medical | 4 | 2022 | 883 | 0.230 |
Why?
|
Cohort Studies | 15 | 2021 | 41808 | 0.230 |
Why?
|
Risk | 4 | 2019 | 9621 | 0.220 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 6 | 1998 | 1141 | 0.220 |
Why?
|
Physical Examination | 2 | 2013 | 1262 | 0.220 |
Why?
|
Brachytherapy | 13 | 1998 | 1224 | 0.220 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2024 | 1399 | 0.220 |
Why?
|
Pre-Eclampsia | 2 | 2024 | 1255 | 0.210 |
Why?
|
Autoimmunity | 1 | 2011 | 1360 | 0.210 |
Why?
|
Glucagonoma | 1 | 2002 | 14 | 0.210 |
Why?
|
Follow-Up Studies | 28 | 2024 | 39394 | 0.210 |
Why?
|
Diagnosis, Differential | 11 | 2021 | 13021 | 0.200 |
Why?
|
Receptors, Thyrotropin | 2 | 2022 | 45 | 0.200 |
Why?
|
Endocrinology | 2 | 2020 | 443 | 0.200 |
Why?
|
Radiation Injuries | 7 | 1995 | 1203 | 0.200 |
Why?
|
Adolescent | 60 | 2021 | 89244 | 0.190 |
Why?
|
Neoplasm Invasiveness | 10 | 2021 | 3629 | 0.190 |
Why?
|
Renal Plasma Flow | 1 | 2021 | 27 | 0.190 |
Why?
|
Boston | 7 | 2016 | 9377 | 0.190 |
Why?
|
Cell Differentiation | 2 | 2016 | 11684 | 0.190 |
Why?
|
Erythema | 1 | 2002 | 261 | 0.190 |
Why?
|
Societies, Medical | 6 | 2017 | 3968 | 0.180 |
Why?
|
Young Adult | 16 | 2021 | 60131 | 0.180 |
Why?
|
Glioma | 17 | 1999 | 3532 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2003 | 1626 | 0.180 |
Why?
|
Subacute Care | 1 | 2023 | 188 | 0.180 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 617 | 0.180 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2021 | 146 | 0.180 |
Why?
|
Terminology as Topic | 2 | 2018 | 1541 | 0.180 |
Why?
|
Pyrroles | 1 | 2006 | 1125 | 0.170 |
Why?
|
Drug Administration Schedule | 7 | 2010 | 4862 | 0.170 |
Why?
|
Craniotomy | 7 | 1999 | 747 | 0.170 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3411 | 0.170 |
Why?
|
DNA Mutational Analysis | 4 | 2018 | 4124 | 0.170 |
Why?
|
Dietary Supplements | 2 | 2024 | 3443 | 0.170 |
Why?
|
Astrocytoma | 10 | 2001 | 781 | 0.170 |
Why?
|
Graves Ophthalmopathy | 1 | 2022 | 135 | 0.170 |
Why?
|
Radiology | 1 | 2013 | 2104 | 0.170 |
Why?
|
False Negative Reactions | 3 | 2018 | 575 | 0.160 |
Why?
|
Premature Birth | 2 | 2024 | 1830 | 0.160 |
Why?
|
Equipment Contamination | 1 | 2001 | 183 | 0.160 |
Why?
|
Gene Expression | 1 | 2012 | 7603 | 0.160 |
Why?
|
Evidence-Based Medicine | 4 | 2020 | 3709 | 0.160 |
Why?
|
Statistics as Topic | 3 | 2015 | 2360 | 0.160 |
Why?
|
Microwaves | 1 | 2020 | 184 | 0.160 |
Why?
|
Monitoring, Intraoperative | 5 | 1999 | 950 | 0.160 |
Why?
|
Cell Nucleus | 2 | 2018 | 2885 | 0.160 |
Why?
|
Military Medicine | 1 | 2000 | 185 | 0.160 |
Why?
|
Indoles | 1 | 2006 | 1836 | 0.150 |
Why?
|
General Surgery | 2 | 2025 | 1722 | 0.150 |
Why?
|
Risk Assessment | 7 | 2022 | 24333 | 0.150 |
Why?
|
Cooperative Behavior | 2 | 2023 | 1515 | 0.150 |
Why?
|
Immunization Programs | 1 | 2000 | 267 | 0.150 |
Why?
|
Postpartum Period | 2 | 2017 | 1198 | 0.150 |
Why?
|
Program Evaluation | 2 | 2020 | 2508 | 0.140 |
Why?
|
Thinking | 1 | 2020 | 320 | 0.140 |
Why?
|
History, 20th Century | 15 | 2000 | 2771 | 0.140 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2433 | 0.140 |
Why?
|
Workplace | 1 | 2023 | 873 | 0.140 |
Why?
|
False Positive Reactions | 1 | 2019 | 963 | 0.140 |
Why?
|
Predictive Value of Tests | 9 | 2021 | 15471 | 0.140 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 395 | 0.140 |
Why?
|
Cholecalciferol | 1 | 2022 | 557 | 0.140 |
Why?
|
Amino Acids | 1 | 2002 | 1716 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 292 | 0.130 |
Why?
|
Algorithms | 4 | 2013 | 14201 | 0.130 |
Why?
|
Stomach Ulcer | 1 | 1996 | 118 | 0.130 |
Why?
|
Substance Abuse, Intravenous | 1 | 2001 | 530 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
Reference Standards | 1 | 2019 | 1014 | 0.130 |
Why?
|
Birth Weight | 2 | 2024 | 2121 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 432 | 0.130 |
Why?
|
Mutation | 8 | 2023 | 30266 | 0.130 |
Why?
|
Disease Management | 2 | 2017 | 2537 | 0.120 |
Why?
|
GTP Phosphohydrolases | 2 | 2017 | 524 | 0.120 |
Why?
|
Time Factors | 16 | 2016 | 40261 | 0.120 |
Why?
|
Gift Giving | 1 | 2015 | 76 | 0.120 |
Why?
|
Scalp | 3 | 1998 | 391 | 0.120 |
Why?
|
ROC Curve | 2 | 2021 | 3629 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2024 | 5323 | 0.120 |
Why?
|
Intraoperative Care | 3 | 1998 | 771 | 0.120 |
Why?
|
Combined Modality Therapy | 9 | 2015 | 8559 | 0.120 |
Why?
|
Brain Injuries | 3 | 1991 | 2058 | 0.120 |
Why?
|
Fatty Acids | 1 | 2002 | 1812 | 0.120 |
Why?
|
Hepatitis B Core Antigens | 1 | 1994 | 90 | 0.120 |
Why?
|
Lactation | 1 | 2017 | 392 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2021 | 2063 | 0.120 |
Why?
|
Cerebral Ventricles | 5 | 1994 | 550 | 0.120 |
Why?
|
Thyroid Hormones | 2 | 2024 | 407 | 0.120 |
Why?
|
United States | 21 | 2023 | 73186 | 0.120 |
Why?
|
Educational Status | 1 | 2022 | 2515 | 0.120 |
Why?
|
Internet | 1 | 2006 | 3112 | 0.110 |
Why?
|
Pregnancy Outcome | 2 | 2022 | 2974 | 0.110 |
Why?
|
Lymph Nodes | 3 | 2022 | 3473 | 0.110 |
Why?
|
Learning | 2 | 2022 | 1760 | 0.110 |
Why?
|
Faculty, Medical | 3 | 2025 | 1226 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2021 | 2884 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 592 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 11 | 2001 | 36854 | 0.110 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2013 | 43 | 0.110 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2018 | 342 | 0.110 |
Why?
|
Health Care Sector | 1 | 2015 | 197 | 0.110 |
Why?
|
Child Day Care Centers | 1 | 1994 | 122 | 0.110 |
Why?
|
Utah | 1 | 2013 | 130 | 0.110 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1994 | 294 | 0.110 |
Why?
|
Image Enhancement | 2 | 2013 | 2898 | 0.110 |
Why?
|
Genomics | 2 | 2022 | 5928 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 6 | 1997 | 9080 | 0.110 |
Why?
|
Microsurgery | 1 | 1999 | 803 | 0.110 |
Why?
|
Phyllodes Tumor | 1 | 2013 | 55 | 0.110 |
Why?
|
Child, Preschool | 39 | 2021 | 42683 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1240 | 0.100 |
Why?
|
Writing | 1 | 2015 | 200 | 0.100 |
Why?
|
Endpoint Determination | 1 | 2015 | 594 | 0.100 |
Why?
|
Neural Tube Defects | 2 | 2001 | 255 | 0.100 |
Why?
|
Galectin 3 | 2 | 2012 | 240 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2460 | 0.100 |
Why?
|
Drug Synergism | 1 | 2016 | 1762 | 0.100 |
Why?
|
Physician-Patient Relations | 3 | 2012 | 3269 | 0.100 |
Why?
|
Radiotherapy Dosage | 9 | 1998 | 2921 | 0.100 |
Why?
|
Prevalence | 6 | 2020 | 15879 | 0.100 |
Why?
|
Phenotype | 4 | 2020 | 16731 | 0.100 |
Why?
|
Neoplasm Metastasis | 4 | 2020 | 4926 | 0.100 |
Why?
|
Nutritional Status | 1 | 2020 | 1627 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5707 | 0.090 |
Why?
|
Triiodothyronine | 2 | 2024 | 492 | 0.090 |
Why?
|
Maternal Welfare | 1 | 2011 | 113 | 0.090 |
Why?
|
Thallium Radioisotopes | 4 | 1998 | 139 | 0.090 |
Why?
|
Preoperative Period | 1 | 2013 | 565 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13698 | 0.090 |
Why?
|
Carrier State | 2 | 1994 | 529 | 0.090 |
Why?
|
Age Factors | 12 | 2019 | 18435 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2013 | 371 | 0.090 |
Why?
|
Infertility, Female | 1 | 2017 | 764 | 0.090 |
Why?
|
Thyroiditis | 2 | 2012 | 86 | 0.090 |
Why?
|
Body Mass Index | 3 | 2024 | 13055 | 0.090 |
Why?
|
Achievement | 1 | 2012 | 288 | 0.090 |
Why?
|
Meningioma | 8 | 1999 | 1226 | 0.090 |
Why?
|
Conflict of Interest | 1 | 2015 | 556 | 0.090 |
Why?
|
Oxyphil Cells | 1 | 2011 | 56 | 0.090 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 2 | 2022 | 34 | 0.090 |
Why?
|
Hepatitis C | 1 | 2001 | 1595 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 377 | 0.090 |
Why?
|
Double-Blind Method | 5 | 2024 | 12467 | 0.090 |
Why?
|
Diabetes, Gestational | 1 | 2020 | 1263 | 0.090 |
Why?
|
Hydrocephalus | 5 | 1992 | 770 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 620 | 0.090 |
Why?
|
Vitamin D | 1 | 2024 | 3311 | 0.090 |
Why?
|
Tongue | 1 | 2013 | 406 | 0.090 |
Why?
|
ras Proteins | 1 | 2015 | 1058 | 0.090 |
Why?
|
Cranial Irradiation | 1 | 1993 | 395 | 0.090 |
Why?
|
Technetium Tc 99m Exametazime | 5 | 1998 | 61 | 0.080 |
Why?
|
Neoplasm Staging | 7 | 2021 | 11262 | 0.080 |
Why?
|
Pituitary Neoplasms | 4 | 1998 | 1326 | 0.080 |
Why?
|
Puerperal Disorders | 1 | 2012 | 304 | 0.080 |
Why?
|
History, 19th Century | 5 | 1998 | 715 | 0.080 |
Why?
|
Craniopharyngioma | 1 | 1992 | 279 | 0.080 |
Why?
|
Etanidazole | 4 | 1998 | 22 | 0.080 |
Why?
|
Radiation, Ionizing | 1 | 1990 | 252 | 0.080 |
Why?
|
Organotechnetium Compounds | 4 | 1993 | 133 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1176 | 0.080 |
Why?
|
Myelography | 1 | 1989 | 72 | 0.080 |
Why?
|
Hepatitis B | 1 | 1994 | 711 | 0.080 |
Why?
|
Brain | 18 | 1999 | 27453 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 1996 | 1798 | 0.080 |
Why?
|
Workload | 1 | 2015 | 852 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1364 | 0.080 |
Why?
|
Cerebral Veins | 1 | 1990 | 159 | 0.080 |
Why?
|
Incidence | 6 | 2024 | 21547 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 859 | 0.080 |
Why?
|
Postoperative Period | 1 | 2013 | 1830 | 0.080 |
Why?
|
Oncogenes | 1 | 2014 | 1236 | 0.080 |
Why?
|
Literature, Modern | 1 | 1988 | 30 | 0.080 |
Why?
|
Child | 45 | 2021 | 80960 | 0.080 |
Why?
|
Wounds, Penetrating | 1 | 1991 | 316 | 0.080 |
Why?
|
Infant, Newborn | 16 | 2024 | 26428 | 0.080 |
Why?
|
Reoperation | 6 | 1999 | 4342 | 0.080 |
Why?
|
Chlamydia Infections | 6 | 1985 | 365 | 0.070 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1990 | 216 | 0.070 |
Why?
|
Radiation-Sensitizing Agents | 3 | 1998 | 349 | 0.070 |
Why?
|
Thyroglobulin | 2 | 2022 | 111 | 0.070 |
Why?
|
Encephalocele | 1 | 1989 | 137 | 0.070 |
Why?
|
Oximes | 4 | 1993 | 303 | 0.070 |
Why?
|
Communication | 1 | 2022 | 3908 | 0.070 |
Why?
|
Risk Factors | 10 | 2024 | 74976 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2297 | 0.070 |
Why?
|
Blast Injuries | 1 | 1991 | 324 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6401 | 0.070 |
Why?
|
Necrosis | 5 | 2021 | 1620 | 0.070 |
Why?
|
Surgical Equipment | 2 | 1997 | 57 | 0.070 |
Why?
|
Eye Neoplasms | 1 | 1989 | 306 | 0.070 |
Why?
|
Survival Rate | 9 | 2018 | 12873 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 12 | 2008 | 20776 | 0.070 |
Why?
|
Tumor Burden | 3 | 2019 | 1913 | 0.070 |
Why?
|
Work Schedule Tolerance | 1 | 2010 | 553 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2011 | 1364 | 0.070 |
Why?
|
Choroid | 1 | 1989 | 363 | 0.070 |
Why?
|
Fetal Diseases | 1 | 2011 | 916 | 0.070 |
Why?
|
Infant | 26 | 2021 | 36556 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21188 | 0.060 |
Why?
|
Sex Factors | 4 | 2015 | 10633 | 0.060 |
Why?
|
Consensus | 3 | 2022 | 3214 | 0.060 |
Why?
|
Vomiting | 4 | 1995 | 655 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2017 | 20245 | 0.060 |
Why?
|
Histocytochemistry | 1 | 2006 | 699 | 0.060 |
Why?
|
Forecasting | 2 | 2013 | 2945 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2002 | 877 | 0.060 |
Why?
|
Interpersonal Relations | 1 | 2012 | 1437 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2002 | 5443 | 0.060 |
Why?
|
Wounds, Gunshot | 1 | 1991 | 588 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3671 | 0.060 |
Why?
|
Treatment Outcome | 13 | 2024 | 65480 | 0.060 |
Why?
|
Carcinoma, Merkel Cell | 1 | 1989 | 329 | 0.060 |
Why?
|
Washington | 4 | 2001 | 315 | 0.060 |
Why?
|
Neoplasms | 6 | 2018 | 22389 | 0.060 |
Why?
|
Fetus | 1 | 2011 | 1882 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11116 | 0.060 |
Why?
|
Radiotherapy | 3 | 1999 | 1506 | 0.060 |
Why?
|
Cervical Vertebrae | 2 | 1981 | 982 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2350 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3810 | 0.060 |
Why?
|
Spinal Diseases | 1 | 1989 | 563 | 0.060 |
Why?
|
Radiography | 10 | 2013 | 6991 | 0.060 |
Why?
|
Sleep Deprivation | 1 | 2010 | 848 | 0.050 |
Why?
|
Neuroma, Acoustic | 3 | 1996 | 458 | 0.050 |
Why?
|
Patient Care Team | 1 | 2015 | 2528 | 0.050 |
Why?
|
Cerebrovascular Disorders | 2 | 1989 | 1486 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2012 | 1789 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4528 | 0.050 |
Why?
|
Sexually Transmitted Diseases | 3 | 1985 | 668 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3608 | 0.050 |
Why?
|
Meningeal Neoplasms | 6 | 1999 | 1258 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1275 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2015 | 14794 | 0.050 |
Why?
|
China | 2 | 2021 | 2395 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4064 | 0.050 |
Why?
|
Patient Simulation | 1 | 2005 | 297 | 0.050 |
Why?
|
Cerebellum | 3 | 1998 | 1522 | 0.050 |
Why?
|
Methimazole | 1 | 2002 | 41 | 0.050 |
Why?
|
Rehabilitation | 1 | 2023 | 129 | 0.050 |
Why?
|
San Francisco | 2 | 2012 | 166 | 0.050 |
Why?
|
Biopsy | 6 | 2013 | 6805 | 0.050 |
Why?
|
Propylthiouracil | 1 | 2002 | 68 | 0.050 |
Why?
|
Prenatal Care | 1 | 2010 | 1162 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8664 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 458 | 0.050 |
Why?
|
Recurrence | 2 | 2013 | 8513 | 0.050 |
Why?
|
Antithyroid Agents | 1 | 2002 | 72 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2017 | 7885 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.050 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 4 | 1998 | 1679 | 0.050 |
Why?
|
Cerebrospinal Fluid Shunts | 3 | 1981 | 197 | 0.050 |
Why?
|
Cervical Atlas | 2 | 1980 | 22 | 0.050 |
Why?
|
Syndrome | 3 | 2002 | 3274 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13674 | 0.050 |
Why?
|
Hypertension, Renal | 1 | 2021 | 135 | 0.050 |
Why?
|
Contrast Media | 3 | 2012 | 5334 | 0.050 |
Why?
|
Feedback | 1 | 2025 | 799 | 0.050 |
Why?
|
Mycoplasma Infections | 3 | 1977 | 120 | 0.050 |
Why?
|
Maternal Age | 1 | 2024 | 805 | 0.050 |
Why?
|
Infusions, Intravenous | 3 | 2002 | 2231 | 0.050 |
Why?
|
Nitroimidazoles | 2 | 1992 | 118 | 0.050 |
Why?
|
Mitotic Index | 1 | 2021 | 162 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11886 | 0.040 |
Why?
|
Gestational Age | 2 | 2020 | 3621 | 0.040 |
Why?
|
Cerebral Ventricle Neoplasms | 2 | 1979 | 43 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 1989 | 1204 | 0.040 |
Why?
|
Escherichia coli O157 | 1 | 2000 | 53 | 0.040 |
Why?
|
Foodborne Diseases | 1 | 2000 | 41 | 0.040 |
Why?
|
Food Microbiology | 1 | 2000 | 74 | 0.040 |
Why?
|
Genes, ras | 1 | 2003 | 665 | 0.040 |
Why?
|
Retreatment | 1 | 2002 | 600 | 0.040 |
Why?
|
Local Government | 1 | 2000 | 83 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2493 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2024 | 12562 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 8094 | 0.040 |
Why?
|
Preoperative Care | 2 | 2004 | 2258 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2000 | 301 | 0.040 |
Why?
|
Social Welfare | 1 | 2000 | 87 | 0.040 |
Why?
|
Diet, Sodium-Restricted | 1 | 2021 | 291 | 0.040 |
Why?
|
Cranial Nerve Diseases | 3 | 1993 | 111 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2010 | 2139 | 0.040 |
Why?
|
Fractures, Closed | 1 | 1980 | 88 | 0.040 |
Why?
|
Nausea | 2 | 1994 | 682 | 0.040 |
Why?
|
Supratentorial Neoplasms | 2 | 1999 | 159 | 0.040 |
Why?
|
Biological Assay | 1 | 2022 | 628 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1447 | 0.040 |
Why?
|
Urinary Diversion | 1 | 1979 | 137 | 0.040 |
Why?
|
Spinal Dysraphism | 1 | 2001 | 179 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 200 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2021 | 640 | 0.040 |
Why?
|
Survival Analysis | 7 | 1998 | 10115 | 0.040 |
Why?
|
Cerebral Hemorrhage | 3 | 1989 | 2660 | 0.040 |
Why?
|
Fasciitis, Necrotizing | 1 | 1999 | 79 | 0.040 |
Why?
|
Chickenpox | 1 | 1999 | 96 | 0.040 |
Why?
|
Treatment Failure | 4 | 1998 | 2664 | 0.040 |
Why?
|
Fractures, Bone | 3 | 1981 | 2063 | 0.040 |
Why?
|
Radiotherapy, High-Energy | 3 | 1998 | 228 | 0.040 |
Why?
|
Otitis Media | 1 | 1980 | 288 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 890 | 0.040 |
Why?
|
Gene Fusion | 1 | 2021 | 357 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1596 | 0.040 |
Why?
|
Arachnoid Cysts | 1 | 1998 | 60 | 0.040 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 1979 | 176 | 0.040 |
Why?
|
Critical Care | 1 | 2010 | 2716 | 0.040 |
Why?
|
Restaurants | 1 | 2000 | 234 | 0.040 |
Why?
|
Ibuprofen | 1 | 1999 | 229 | 0.040 |
Why?
|
State Government | 1 | 2000 | 389 | 0.040 |
Why?
|
Chicago | 1 | 1998 | 255 | 0.040 |
Why?
|
Meningomyelocele | 1 | 1979 | 182 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2012 | 6236 | 0.040 |
Why?
|
Fracture Fixation | 1 | 1980 | 371 | 0.040 |
Why?
|
Meat | 1 | 2000 | 588 | 0.040 |
Why?
|
Craniocerebral Trauma | 2 | 1972 | 495 | 0.040 |
Why?
|
Escherichia coli Infections | 2 | 2000 | 524 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 12806 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 702 | 0.030 |
Why?
|
Estradiol | 1 | 2004 | 1952 | 0.030 |
Why?
|
Financing, Government | 1 | 2000 | 473 | 0.030 |
Why?
|
Cerebellar Neoplasms | 3 | 1996 | 591 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1645 | 0.030 |
Why?
|
Baltimore | 1 | 1997 | 233 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8745 | 0.030 |
Why?
|
Computer Simulation | 1 | 2010 | 6291 | 0.030 |
Why?
|
raf Kinases | 1 | 2016 | 117 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1250 | 0.030 |
Why?
|
Hemangioblastoma | 1 | 1996 | 62 | 0.030 |
Why?
|
Adenoma, Oxyphilic | 2 | 2011 | 152 | 0.030 |
Why?
|
Clinical Trials as Topic | 6 | 2010 | 8055 | 0.030 |
Why?
|
Patient Selection | 2 | 2018 | 4265 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13318 | 0.030 |
Why?
|
Radium | 1 | 1996 | 70 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 872 | 0.030 |
Why?
|
Reference Values | 1 | 2022 | 4940 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2016 | 252 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3928 | 0.030 |
Why?
|
Managed Care Programs | 1 | 2000 | 941 | 0.030 |
Why?
|
Equipment Design | 3 | 1999 | 3530 | 0.030 |
Why?
|
Odds Ratio | 3 | 2005 | 9684 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 18068 | 0.030 |
Why?
|
Fetal Development | 1 | 2020 | 777 | 0.030 |
Why?
|
New York City | 1 | 1997 | 737 | 0.030 |
Why?
|
Chlamydia trachomatis | 5 | 1984 | 239 | 0.030 |
Why?
|
Interinstitutional Relations | 1 | 2015 | 236 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1143 | 0.030 |
Why?
|
Computer Systems | 1 | 1996 | 470 | 0.030 |
Why?
|
Glomus Jugulare Tumor | 1 | 1994 | 35 | 0.030 |
Why?
|
Serotyping | 1 | 1994 | 331 | 0.030 |
Why?
|
Pons | 1 | 1995 | 242 | 0.030 |
Why?
|
Remission Induction | 2 | 1990 | 2408 | 0.030 |
Why?
|
Computer Graphics | 1 | 1996 | 344 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5457 | 0.030 |
Why?
|
Abducens Nerve | 1 | 1993 | 28 | 0.030 |
Why?
|
Trochlear Nerve | 1 | 1993 | 26 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2000 | 857 | 0.030 |
Why?
|
Ondansetron | 1 | 1994 | 95 | 0.030 |
Why?
|
Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
Life Style | 1 | 2005 | 3931 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 1999 | 1793 | 0.030 |
Why?
|
Urethritis | 4 | 1984 | 30 | 0.030 |
Why?
|
Oculomotor Nerve | 1 | 1993 | 72 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 2858 | 0.030 |
Why?
|
Transcription Factors | 2 | 2003 | 12174 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5375 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 737 | 0.030 |
Why?
|
Pilot Projects | 2 | 2005 | 8748 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 1991 | 5864 | 0.030 |
Why?
|
South Dakota | 1 | 2012 | 32 | 0.030 |
Why?
|
Carmustine | 3 | 1983 | 137 | 0.030 |
Why?
|
Anesthesia, Local | 1 | 1995 | 279 | 0.030 |
Why?
|
Radiation Dosage | 2 | 1999 | 1970 | 0.030 |
Why?
|
Cavernous Sinus | 1 | 1993 | 122 | 0.030 |
Why?
|
Social Security | 1 | 2012 | 101 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2005 | 4045 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2014 | 426 | 0.020 |
Why?
|
Disease Outbreaks | 2 | 2000 | 1761 | 0.020 |
Why?
|
Public Health | 1 | 1985 | 2680 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 3438 | 0.020 |
Why?
|
Trigeminal Nerve | 1 | 1993 | 248 | 0.020 |
Why?
|
Cerebral Angiography | 5 | 1990 | 1272 | 0.020 |
Why?
|
Vaccines | 1 | 2000 | 843 | 0.020 |
Why?
|
Therapy, Computer-Assisted | 1 | 1994 | 265 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1159 | 0.020 |
Why?
|
Schools | 1 | 2000 | 1498 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 1993 | 478 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1981 | 1313 | 0.020 |
Why?
|
Arginine | 2 | 1994 | 932 | 0.020 |
Why?
|
Radiology, Interventional | 1 | 1995 | 483 | 0.020 |
Why?
|
Brain Diseases | 3 | 1995 | 1558 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4199 | 0.020 |
Why?
|
Registries | 2 | 2012 | 8384 | 0.020 |
Why?
|
Adenoma | 2 | 1998 | 2163 | 0.020 |
Why?
|
Herpesvirus 3, Human | 1 | 1971 | 159 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26395 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 1992 | 160 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6856 | 0.020 |
Why?
|
Skull | 3 | 1981 | 830 | 0.020 |
Why?
|
Birds | 1 | 1991 | 166 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6547 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 1971 | 269 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1974 | 542 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3491 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 836 | 0.020 |
Why?
|
Optic Nerve | 1 | 1993 | 571 | 0.020 |
Why?
|
Alopecia | 2 | 1994 | 416 | 0.020 |
Why?
|
Arteriovenous Fistula | 2 | 1970 | 320 | 0.020 |
Why?
|
Operating Rooms | 1 | 1996 | 793 | 0.020 |
Why?
|
Hemiplegia | 1 | 1990 | 137 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 859 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 1994 | 560 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2056 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2276 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1281 | 0.020 |
Why?
|
Videotape Recording | 1 | 2010 | 335 | 0.020 |
Why?
|
Postoperative Complications | 7 | 1998 | 15889 | 0.020 |
Why?
|
Adenoviridae Infections | 1 | 1969 | 96 | 0.020 |
Why?
|
Mental Disorders | 1 | 1989 | 6876 | 0.020 |
Why?
|
Incidental Findings | 1 | 2013 | 697 | 0.020 |
Why?
|
Heart Failure | 1 | 2013 | 11879 | 0.020 |
Why?
|
Gamma Rays | 1 | 1990 | 319 | 0.020 |
Why?
|
Patient Care Planning | 2 | 1994 | 904 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1194 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2280 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 4056 | 0.020 |
Why?
|
Video Recording | 1 | 1994 | 976 | 0.020 |
Why?
|
Smoking | 1 | 2005 | 9094 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5804 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1998 | 2734 | 0.020 |
Why?
|
Intussusception | 1 | 1969 | 116 | 0.020 |
Why?
|
Aphasia | 1 | 1990 | 193 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2012 | 22296 | 0.020 |
Why?
|
Linear Models | 1 | 1998 | 5891 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1995 | 1495 | 0.020 |
Why?
|
Palpation | 1 | 2008 | 166 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 17173 | 0.020 |
Why?
|
Gene Rearrangement | 2 | 2003 | 1148 | 0.020 |
Why?
|
Pneumonia | 3 | 1969 | 2164 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1189 | 0.020 |
Why?
|
Arteriovenous Malformations | 4 | 1996 | 396 | 0.020 |
Why?
|
Nitric Oxide | 2 | 1994 | 2149 | 0.020 |
Why?
|
Palliative Care | 1 | 2002 | 3644 | 0.020 |
Why?
|
Mycoplasma | 2 | 1966 | 146 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1971 | 753 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2012 | 757 | 0.020 |
Why?
|
Blindness | 1 | 1971 | 587 | 0.020 |
Why?
|
Neurologic Examination | 3 | 1996 | 916 | 0.020 |
Why?
|
Actuarial Analysis | 2 | 1999 | 372 | 0.020 |
Why?
|
Syphilis, Congenital | 1 | 1985 | 26 | 0.020 |
Why?
|
Signal Transduction | 2 | 2021 | 23653 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9618 | 0.020 |
Why?
|
Suture Techniques | 2 | 1981 | 779 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6086 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5544 | 0.020 |
Why?
|
Craniosynostoses | 2 | 1974 | 416 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2784 | 0.020 |
Why?
|
Gadolinium DTPA | 2 | 1998 | 823 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 2744 | 0.010 |
Why?
|
Protons | 1 | 1990 | 1113 | 0.010 |
Why?
|
Herpes Genitalis | 1 | 1985 | 149 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1990 | 1445 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1991 | 1145 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2241 | 0.010 |
Why?
|
Antibodies | 1 | 1971 | 2422 | 0.010 |
Why?
|
Postoperative Care | 1 | 1990 | 1481 | 0.010 |
Why?
|
Procarbazine | 1 | 1983 | 172 | 0.010 |
Why?
|
Models, Structural | 2 | 1993 | 340 | 0.010 |
Why?
|
Drug Evaluation | 3 | 1992 | 642 | 0.010 |
Why?
|
Syphilis | 1 | 1985 | 243 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1997 | 3538 | 0.010 |
Why?
|
Paired Box Transcription Factors | 1 | 2003 | 206 | 0.010 |
Why?
|
Acute Disease | 3 | 1990 | 7245 | 0.010 |
Why?
|
Medicare | 1 | 2000 | 6888 | 0.010 |
Why?
|
Pinealoma | 2 | 1999 | 52 | 0.010 |
Why?
|
Temporal Lobe | 3 | 1979 | 1728 | 0.010 |
Why?
|
Informed Consent | 1 | 2008 | 1010 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 10400 | 0.010 |
Why?
|
Laminectomy | 2 | 1981 | 226 | 0.010 |
Why?
|
Tetracyclines | 1 | 1981 | 64 | 0.010 |
Why?
|
Medical Illustration | 2 | 1990 | 135 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1983 | 386 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6673 | 0.010 |
Why?
|
Codon | 1 | 2003 | 599 | 0.010 |
Why?
|
Nitrosourea Compounds | 1 | 1980 | 32 | 0.010 |
Why?
|
Phenytoin | 2 | 1972 | 189 | 0.010 |
Why?
|
Qualitative Research | 1 | 2012 | 3143 | 0.010 |
Why?
|
Sex Offenses | 1 | 1985 | 357 | 0.010 |
Why?
|
Pineal Gland | 2 | 1999 | 158 | 0.010 |
Why?
|
Phenobarbital | 2 | 1972 | 192 | 0.010 |
Why?
|
Gonorrhea | 1 | 1985 | 355 | 0.010 |
Why?
|
Bacteriophage Typing | 1 | 2000 | 3 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 1991 | 2182 | 0.010 |
Why?
|
Northwestern United States | 1 | 2000 | 20 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 1981 | 135 | 0.010 |
Why?
|
Pyuria | 1 | 1980 | 30 | 0.010 |
Why?
|
Traction | 1 | 1981 | 112 | 0.010 |
Why?
|
Psychosurgery | 1 | 1981 | 86 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2015 | 4339 | 0.010 |
Why?
|
Acrylic Resins | 1 | 1981 | 135 | 0.010 |
Why?
|
Urethral Diseases | 1 | 1980 | 52 | 0.010 |
Why?
|
Minocycline | 1 | 1981 | 170 | 0.010 |
Why?
|
Radionuclide Imaging | 3 | 1970 | 1998 | 0.010 |
Why?
|
North Carolina | 1 | 1981 | 329 | 0.010 |
Why?
|
Oligodendroglioma | 2 | 1993 | 278 | 0.010 |
Why?
|
Medulloblastoma | 2 | 1996 | 683 | 0.010 |
Why?
|
Pneumoencephalography | 1 | 1979 | 22 | 0.010 |
Why?
|
Food Handling | 1 | 2000 | 158 | 0.010 |
Why?
|
Complement Fixation Tests | 2 | 1971 | 68 | 0.010 |
Why?
|
Kidney Calices | 1 | 1979 | 26 | 0.010 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 1999 | 43 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1536 | 0.010 |
Why?
|
Financing, Organized | 1 | 1981 | 203 | 0.010 |
Why?
|
Aneuploidy | 1 | 2003 | 573 | 0.010 |
Why?
|
Germany | 1 | 1981 | 883 | 0.010 |
Why?
|
Urination Disorders | 1 | 1980 | 238 | 0.010 |
Why?
|
Pyelonephritis | 1 | 1979 | 76 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8894 | 0.010 |
Why?
|
Ribs | 1 | 1981 | 259 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1991 | 4428 | 0.010 |
Why?
|
Neurology | 1 | 1967 | 787 | 0.010 |
Why?
|
Sarcoma | 1 | 1990 | 1806 | 0.010 |
Why?
|
Colon, Sigmoid | 1 | 1979 | 124 | 0.010 |
Why?
|
Software | 1 | 1993 | 4479 | 0.010 |
Why?
|
Blood Transfusion | 3 | 1972 | 1309 | 0.010 |
Why?
|
Airway Obstruction | 2 | 1995 | 672 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1866 | 0.010 |
Why?
|
Epididymitis | 1 | 1978 | 37 | 0.010 |
Why?
|
Intraoperative Period | 1 | 1999 | 513 | 0.010 |
Why?
|
Paralysis | 2 | 1977 | 250 | 0.010 |
Why?
|
Kidney Pelvis | 1 | 1979 | 195 | 0.010 |
Why?
|
Hydronephrosis | 1 | 1979 | 274 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1979 | 527 | 0.010 |
Why?
|
Seasons | 3 | 1969 | 1524 | 0.010 |
Why?
|
Immunoelectrophoresis, Two-Dimensional | 1 | 1977 | 2 | 0.010 |
Why?
|
Spinal Injuries | 1 | 1981 | 300 | 0.010 |
Why?
|
Immunoelectrophoresis | 1 | 1977 | 94 | 0.010 |
Why?
|
Antibodies, Bacterial | 2 | 1980 | 1478 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2013 | 3431 | 0.010 |
Why?
|
Plicamycin | 1 | 1976 | 12 | 0.010 |
Why?
|
Ileum | 1 | 1979 | 558 | 0.010 |
Why?
|
Child Abuse | 1 | 1985 | 1091 | 0.010 |
Why?
|
Hypopituitarism | 1 | 1998 | 253 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 2 | 1985 | 2190 | 0.010 |
Why?
|
Urinary Tract Infections | 2 | 1980 | 805 | 0.010 |
Why?
|
Cerebellopontine Angle | 1 | 1996 | 53 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4592 | 0.010 |
Why?
|
Intracranial Aneurysm | 1 | 1966 | 1293 | 0.010 |
Why?
|
Nurses | 1 | 2005 | 2501 | 0.010 |
Why?
|
Ethmoid Sinusitis | 1 | 1995 | 25 | 0.010 |
Why?
|
Vesico-Ureteral Reflux | 1 | 1979 | 433 | 0.010 |
Why?
|
Intubation, Intratracheal | 2 | 1995 | 1359 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1981 | 1669 | 0.010 |
Why?
|
Prochlorperazine | 1 | 1994 | 16 | 0.010 |
Why?
|
Maxillary Sinusitis | 1 | 1995 | 41 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10486 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1981 | 716 | 0.010 |
Why?
|
Medulla Oblongata | 1 | 1996 | 248 | 0.010 |
Why?
|
Urinary Incontinence | 1 | 1979 | 496 | 0.010 |
Why?
|
Urethra | 3 | 1984 | 407 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1995 | 175 | 0.010 |
Why?
|
Cattle | 1 | 2000 | 3819 | 0.010 |
Why?
|
Heart Atria | 1 | 1981 | 1361 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 1996 | 624 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1994 | 108 | 0.010 |
Why?
|
Fracture Fixation, Internal | 1 | 1981 | 982 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 1995 | 160 | 0.010 |
Why?
|
Prosthesis Design | 1 | 1981 | 2126 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1994 | 262 | 0.010 |
Why?
|
Intracranial Pressure | 2 | 1974 | 325 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 1999 | 812 | 0.010 |
Why?
|
Random Allocation | 3 | 1983 | 2394 | 0.010 |
Why?
|
Cervix Uteri | 3 | 1984 | 577 | 0.010 |
Why?
|
Craniofacial Dysostosis | 1 | 1972 | 74 | 0.010 |
Why?
|
Shock, Septic | 1 | 1999 | 774 | 0.010 |
Why?
|
Decerebrate State | 1 | 1972 | 42 | 0.010 |
Why?
|
Plasma Substitutes | 1 | 1972 | 58 | 0.010 |
Why?
|
Chromaffin System | 1 | 1951 | 15 | 0.010 |
Why?
|
Glomus Jugulare | 1 | 1951 | 4 | 0.010 |
Why?
|
Embolism, Fat | 1 | 1972 | 46 | 0.010 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 1972 | 59 | 0.010 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 1951 | 47 | 0.010 |
Why?
|
Subarachnoid Space | 1 | 1971 | 79 | 0.010 |
Why?
|
Mannitol | 1 | 1972 | 177 | 0.010 |
Why?
|
Melanoma | 1 | 1990 | 5709 | 0.010 |
Why?
|
Thallium | 1 | 1991 | 100 | 0.010 |
Why?
|
Colon | 1 | 1979 | 1803 | 0.010 |
Why?
|
Cough | 1 | 1995 | 598 | 0.010 |
Why?
|
Hematoma, Subdural | 1 | 1972 | 128 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1972 | 145 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1991 | 229 | 0.010 |
Why?
|
Hyperbaric Oxygenation | 1 | 1972 | 166 | 0.010 |
Why?
|
Canada | 2 | 1974 | 2130 | 0.010 |
Why?
|
Verapamil | 1 | 1991 | 242 | 0.010 |
Why?
|
Abducens Nerve Diseases | 1 | 1971 | 44 | 0.010 |
Why?
|
Conscious Sedation | 1 | 1995 | 534 | 0.010 |
Why?
|
Skull Fractures | 1 | 1972 | 203 | 0.010 |
Why?
|
Animals | 4 | 2000 | 169335 | 0.010 |
Why?
|
Paraganglioma | 1 | 1951 | 143 | 0.010 |
Why?
|
Unconsciousness | 1 | 1972 | 251 | 0.010 |
Why?
|
Spinal Puncture | 1 | 1972 | 286 | 0.010 |
Why?
|
Cross Reactions | 1 | 1971 | 828 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1984 | 1629 | 0.010 |
Why?
|
Urea | 1 | 1972 | 448 | 0.010 |
Why?
|
Demeclocycline | 1 | 1969 | 5 | 0.010 |
Why?
|
Ear, Middle | 1 | 1951 | 341 | 0.000 |
Why?
|
Acetylcholine | 1 | 1991 | 629 | 0.000 |
Why?
|
Erythromycin | 1 | 1969 | 115 | 0.000 |
Why?
|
Antigens, Neoplasm | 1 | 1977 | 2001 | 0.000 |
Why?
|
Enterovirus Infections | 1 | 1969 | 74 | 0.000 |
Why?
|
Kyphosis | 1 | 1971 | 253 | 0.000 |
Why?
|
Mesentery | 1 | 1969 | 202 | 0.000 |
Why?
|
Pneumonia, Viral | 1 | 1966 | 3241 | 0.000 |
Why?
|
Ecology | 1 | 1969 | 105 | 0.000 |
Why?
|
Equipment Failure | 1 | 1971 | 585 | 0.000 |
Why?
|
Taiwan | 1 | 1969 | 524 | 0.000 |
Why?
|
Monte Carlo Method | 1 | 1993 | 1262 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1971 | 996 | 0.000 |
Why?
|
Periodicity | 1 | 1969 | 348 | 0.000 |
Why?
|
Urine | 2 | 1980 | 362 | 0.000 |
Why?
|
User-Computer Interface | 1 | 1994 | 1406 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1996 | 1892 | 0.000 |
Why?
|
Headache | 1 | 1995 | 1264 | 0.000 |
Why?
|
Vasodilation | 1 | 1991 | 967 | 0.000 |
Why?
|
Trachoma | 1 | 1966 | 19 | 0.000 |
Why?
|
Parkinson Disease | 1 | 1981 | 2895 | 0.000 |
Why?
|
Hypothermia, Induced | 1 | 1972 | 756 | 0.000 |
Why?
|
Pharynx | 1 | 1969 | 436 | 0.000 |
Why?
|
Cerebral Ventriculography | 1 | 1966 | 44 | 0.000 |
Why?
|
Polyethylenes | 2 | 1971 | 293 | 0.000 |
Why?
|
Serotonin | 1 | 1991 | 1043 | 0.000 |
Why?
|
Dexamethasone | 1 | 1994 | 1965 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6131 | 0.000 |
Why?
|
Technetium | 1 | 1966 | 326 | 0.000 |
Why?
|
Brain Stem | 1 | 1971 | 862 | 0.000 |
Why?
|
Measles Vaccine | 1 | 1966 | 80 | 0.000 |
Why?
|
Carotid Arteries | 1 | 1970 | 943 | 0.000 |
Why?
|
Cause of Death | 1 | 1996 | 3721 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12095 | 0.000 |
Why?
|
Cranial Fossa, Posterior | 1 | 1966 | 134 | 0.000 |
Why?
|
Adenoviridae | 1 | 1969 | 1095 | 0.000 |
Why?
|
Quality of Life | 2 | 1999 | 13510 | 0.000 |
Why?
|
Rabbits | 1 | 1991 | 4774 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1977 | 2044 | 0.000 |
Why?
|
Rectum | 1 | 1969 | 900 | 0.000 |
Why?
|
Pelvic Inflammatory Disease | 1 | 1984 | 95 | 0.000 |
Why?
|
Scoliosis | 1 | 1971 | 793 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1995 | 2725 | 0.000 |
Why?
|
Urban Population | 1 | 1971 | 2046 | 0.000 |
Why?
|
Bacteriological Techniques | 1 | 1984 | 277 | 0.000 |
Why?
|
Inclusion Bodies | 1 | 1984 | 279 | 0.000 |
Why?
|
Citrates | 1 | 1963 | 134 | 0.000 |
Why?
|
Social Class | 1 | 1971 | 2009 | 0.000 |
Why?
|
Epidemiologic Methods | 1 | 1967 | 1328 | 0.000 |
Why?
|
Papilloma | 1 | 1963 | 143 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1972 | 2167 | 0.000 |
Why?
|
Lateral Ventricles | 1 | 1963 | 145 | 0.000 |
Why?
|
Metabolism | 1 | 1963 | 193 | 0.000 |
Why?
|
Hypothermia | 1 | 1963 | 189 | 0.000 |
Why?
|
Semustine | 1 | 1980 | 11 | 0.000 |
Why?
|
Acidosis | 1 | 1963 | 271 | 0.000 |
Why?
|
Antibody-Coated Bacteria Test, Urinary | 1 | 1980 | 6 | 0.000 |
Why?
|
Pheochromocytoma | 1 | 1963 | 328 | 0.000 |
Why?
|
Respiratory Tract Infections | 1 | 1969 | 1014 | 0.000 |
Why?
|
Hyperkalemia | 1 | 1963 | 234 | 0.000 |
Why?
|
Recovery of Function | 1 | 1971 | 2990 | 0.000 |
Why?
|
Choroid Plexus | 1 | 1963 | 250 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1984 | 2474 | 0.000 |
Why?
|
Cystitis | 1 | 1980 | 96 | 0.000 |
Why?
|
Ependymoma | 1 | 1963 | 328 | 0.000 |
Why?
|
Bacteriuria | 1 | 1980 | 102 | 0.000 |
Why?
|
Posture | 1 | 1964 | 957 | 0.000 |
Why?
|
Cytokines | 1 | 1994 | 7453 | 0.000 |
Why?
|
Sulfisoxazole | 1 | 1977 | 8 | 0.000 |
Why?
|
Gardnerella vaginalis | 1 | 1977 | 20 | 0.000 |
Why?
|
Ureaplasma | 1 | 1977 | 59 | 0.000 |
Why?
|
Seizures | 1 | 1970 | 3000 | 0.000 |
Why?
|
Antigen-Antibody Reactions | 1 | 1977 | 342 | 0.000 |
Why?
|
Models, Biological | 1 | 1993 | 9499 | 0.000 |
Why?
|
Enterobacteriaceae Infections | 1 | 1978 | 190 | 0.000 |
Why?
|
Blood | 1 | 1978 | 599 | 0.000 |
Why?
|
Urinary Bladder | 1 | 1980 | 1162 | 0.000 |
Why?
|
Vaccination | 1 | 1966 | 3438 | 0.000 |
Why?
|
Pseudomonas Infections | 1 | 1978 | 623 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1972 | 7478 | 0.000 |
Why?
|
Cephalometry | 1 | 1974 | 380 | 0.000 |
Why?
|
Arachnoiditis | 1 | 1971 | 9 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1977 | 538 | 0.000 |
Why?
|
Meningocele | 1 | 1971 | 50 | 0.000 |
Why?
|
Depression | 1 | 1970 | 8231 | 0.000 |
Why?
|
Lumbosacral Region | 1 | 1971 | 294 | 0.000 |
Why?
|
Bacteria | 1 | 1980 | 2216 | 0.000 |
Why?
|
Central Nervous System | 1 | 1956 | 1346 | 0.000 |
Why?
|
Central Nervous System Neoplasms | 1 | 1956 | 930 | 0.000 |
Why?
|
Aneurysm | 1 | 1969 | 343 | 0.000 |
Why?
|
Leg | 1 | 1971 | 1089 | 0.000 |
Why?
|
British Columbia | 1 | 1966 | 240 | 0.000 |
Why?
|
Tetracycline | 1 | 1966 | 216 | 0.000 |
Why?
|
Georgia | 1 | 1966 | 186 | 0.000 |
Why?
|
Catheterization | 1 | 1971 | 1431 | 0.000 |
Why?
|
Ohio | 1 | 1966 | 321 | 0.000 |
Why?
|
Immunization Schedule | 1 | 1966 | 228 | 0.000 |
Why?
|
Spine | 1 | 1971 | 1141 | 0.000 |
Why?
|
New York | 1 | 1966 | 884 | 0.000 |
Why?
|
Functional Laterality | 1 | 1969 | 2267 | 0.000 |
Why?
|
Placebos | 1 | 1966 | 1667 | 0.000 |
Why?
|
India | 1 | 1966 | 2334 | 0.000 |
Why?
|
Epilepsy | 1 | 1969 | 3326 | 0.000 |
Why?
|